MarketScreener Strategies Medexus Pharmaceuticals Inc.

Equities

Delayed Toronto S.E. Other stock markets 08:00:12 21/05/2024 pm IST			5-day change	1st Jan Change
1.62 ^CAD	+1.25%		+1.25%	-34.41%

26/03	Medexus Pharmaceuticals Announces US Food and Drug Administration Approves It's Supplemental Biologics License Application for IXINITY(R)	CI
09/02	Medexus Pharmaceuticals Maintained at Speculative Buy at Stifel GMP After Fiscal Q3 Miss; Price Target Cut to C$2.85	MT

No results for this search